International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 15: [Related article:] 6825-6830, 2018; DOI: 10.3892/ol.2018.8225
We wish to retract our research article entitled “Analysis of expression of YAP1 and TAZ by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells” published in Oncology Letters 15 6825–6830, 2018. Following the publication of this article, an interested reader drew to our attention that, owing to an error on our part, there were fundamental flaws in the data integrity and the experimental design of this study such that neither the results nor the conclusions may be regarded as being reliable. [Essentially, the acronym ‘TAZ’ (or WW domain-containing transcription regulator 1; WWTR1), a transcriptional coactivator acting as an effector of the Hippo pathway that was our intended protein for study, was confused with the protein, tafazzin (TAZ).]
All the named authors agree to this retraction. We sincerely apologize for this mistake, and thank the reader of our article who drew this matter to our attention. Furthermore, we regret any inconvenience this mistake has caused.